Glucocorticoids and Mineralocorticoids
Glucocorticoids and mineralocorticoids are two types of corticosteroids, which are steroid hormones produced by the adrenal cortex.
Classification
- Short-acting glucocorticoids:
- Cortisone
- Hydrocortisone
- Intermediate-acting glucocorticoids:
- Prednisone
- Prednisolone
- Methylprednisolone
- Long-acting glucocorticoids:
- Betamethasone
- Dexamethasone
- Mineralocorticoid:
- Natural: Aldosterone
- Synthetic: Fludrocortisone
Pharmacodynamics
- Glucocorticoids:
- Anti-inflammatory effects: Glucocorticoids inhibit the production of inflammatory mediators such as prostaglandins, leukotrienes, and cytokines. They reduce the activity and migration of immune cells to sites of inflammation, decreasing swelling, redness, and pain.
- Immunosuppressive effects: By suppressing immune system activity, glucocorticoids reduce the production of antibodies and other immune responses.
- Metabolic effects: They increase gluconeogenesis in the liver, decrease glucose uptake in muscle and fat tissue, and promote protein and lipid breakdown.
- Mineralocorticoids:
- Primarily aldosterone, these act on the distal tubules and collecting ducts of the kidneys to promote sodium reabsorption. This leads to the retention of sodium and water, which helps maintain blood pressure and fluid balance.
Pharmacokinetics
- Cortisone:
- Administered orally or via intramuscular injection. It is converted in the liver to hydrocortisone (cortisol) when taken orally.
- Oral bioavailability: 20-30%.
- Half-life: 30 minutes to 1 hour.
- Duration: 8-12 hours.
- Prednisone:
- Administered orally, intravenously, or intramuscularly. It is converted in the liver to its active form, prednisolone.
- Oral bioavailability: 80%.
- Half-life (prednisolone): 2-4 hours.
- Duration: 12-36 hours.
- Dexamethasone:
- Available in oral, intravenous, intramuscular, and topical forms.
- Highly bioavailable orally.
- Half-life: 36-72 hours.
- Duration: Long-acting.
- Fludrocortisone:
- Synthetic mineralocorticoid, administered orally, intravenously, or intramuscularly.
- Oral bioavailability: 90-95%.
- Half-life: 3.5 hours.
- Biological effects last 18-36 hours.
- Potent mineralocorticoid activity.
Side Effects
- Common side effects:
- Hypertension
- Ulcerogenic effects
- Menstrual cycle disturbances
- Metabolic disorders, such as Cushing Syndrome
- Risk of thrombosis
- Depression
Drug Interactions
- NSAIDs: Increased risk of GI bleeding.
- Antidiabetic medications: Reduced effectiveness.
- Anticoagulants (e.g., warfarin): Altered effects.
- Diuretics: Increased risk of hypokalemia.
- Ketoconazole: Enhanced effects.
- Vaccines: Reduced effectiveness.
Therapeutic Use
- Glucocorticoids:
- Autoimmune diseases
- Asthma
- COPD (Chronic Obstructive Pulmonary Disease)
- Allergic reactions
- Rheumatoid arthritis
- Inflammatory bowel disease
- Lupus
- Multiple sclerosis
- Dermatologic conditions
- Transplant rejection prophylaxis
- Adrenal insufficiency
- Mineralocorticoids:
- Addison’s disease
- Adrenal insufficiency
- Orthostatic hypotension
Pregnancy and Milk
- Glucocorticoids:
- Short-term use has the lowest risk.
- Should be used with caution during pregnancy.
- Can be used during lactation with low risk.